The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic
Background: Patients with inflammatory bowel disease (IBD) often require the use of immunosuppressant medications that increase infection risk, leading to concerns over the safe use of IBD medications during the Coronavirus 19 (COVID-19) pandemic. Objectives: To summarize available evidence on the s...
Main Authors: | Chethana Kamath, MD, Erica J Brenner, MD, MSCR |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Current Research in Pharmacology and Drug Discovery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590257122000219 |
Similar Items
-
Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients
by: Michał Łodyga, et al.
Published: (2021-08-01) -
Evaluation of the COVID-19 Fear and Quality of Life in Patients with Inflammatory Bowel Disease During the Pandemic
by: Rasim Eren Cankurtaran, et al.
Published: (2022-03-01) -
Mental health evaluation of patients with Inflammatory Bowel Disease and psychiatric comorbidities during the COVID-19 pandemic
by: S. Vanzetto, et al.
Published: (2022-06-01) -
Safe Sexual Practices in the COVID-19 Pandemic Period
by: Lucia Alves da Silva Lara, MD, PhD, et al.
Published: (2020-12-01) -
COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
by: Aleksandra Kubas, et al.
Published: (2022-05-01)